Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL）

NCT05977257 is registered in ClinicalTrials.gov with Shanghai MicroPort CardioFlow Medtech Co., Ltd. as lead sponsor.

NCT NCT05977257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05977257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL）
Lead sponsor
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Phase
Observational
Overall status
Not yet recruiting
Start date
July 30, 2023
Completion date
October 30, 2028
Enrollment
89 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease, aortic valve stenosis